Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-18
1999-02-02
Trinh, Ba K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549475, A61K 3134, C07D30732
Patent
active
058666028
ABSTRACT:
Keto-substituted tetrahydrofuran analogs of prostaglandins and methods of their use in treating glaucoma and ocular hypertension are disclosed.
REFERENCES:
patent: 3883659 (1975-05-01), Vlattas
patent: 4088779 (1978-05-01), Vlattas
patent: 4133817 (1979-01-01), Lourens et al.
patent: 4133948 (1979-01-01), Lourens et al.
patent: 4599353 (1986-07-01), Bito
patent: 5321128 (1994-06-01), Stjernschantz et al.
patent: 5574066 (1996-11-01), Chan et al.
Alm, "The Potential of Prostaglandin Derivatives in Glaucoma Therapy" Current Opinion in Ophthalmology 4(11):44-50 (1993).
Arndt et al., "Stereospecific Synthesis of Modified Prostaglandins Derived from Carbohydrates. Part 1." S. Afr. J. Chem. 34(4):121-127 (Jun. 1981).
Flach et al., "Topical Prostaglandin E.sub.2 Effects on Normal Human Intraocular Pressure" Journal of Ocular Pharmacology 4(1):13-18 (1988).
Giuffre, "The Effects of Prostaglandin F.sub.2.alpha. the Human Eye" Graefe's Arch Clin Exp Ophthalmol 222:139-141 (1985).
Hanessian et al., "Total Synthesis of 11-Oxaprostaglandin F.sub.2.alpha. and F.sub.2.beta. " Carbohydrate Research 141(2):221-238 XP000644751 (1985).
Ichikawa, et al., "Molecular Aspects of the Structures and Functions of the Prostaglandin E Receptors" J. Lipid Mediators Cell Signaling 14:83-87 (1996).
Kerstetter et al., "Prostaglandin F.sub.2.alpha. -1-Isopropylester Lowers Intraocular Pressure Without Decreasing Aqueous Humor Flow" American Journal of Ophthalmology 105:30-34 (1988).
Lourens et al., "The Novel Stereospecific Synthesis of 11-oxapros-taglandin F.sub.2.alpha. " Tetrahedron Letters, No. 43:3719-3722 Pergamon Press (1975).
Nakajima et al., "Effects of Prostaglandin D.sub.2 and its Analog, BW245C, on Intraocular Pressure in Humans" Graefe's Arch Clin Exp Ophthalmol 229:411-413 (1991).
Theim et al., "Synthese von Qxaprostaglandinen aus 1,4:3,6-Dianhydro-D-sorbit" Liebigs Ann. Chem. 2151:2164 XP0006444761 (1985).
Thierauch et al., "Prostaglandins and Their Receptors: II. Receptor Structure and Signal Transduction" Journal of Hypertension 12:1-5 (1994).
Verdoorn et al., "Synthesis of Methyl (5Z,13E(15S)-9.alpha.-acetoxy-15-hydroxy-17-(3-trifluoromethylphenyl)-11-o xa-18,19,20-trinorprosta-5,13-dienoate" S. Afr. Tydskr. Chem. 40(2):134-138 XP000618452 (1987).
Vlattas et al., "Synthesis of 9-Oxaprostaglandins" Tetrahedron Letters No. 51/52:4455-4458, Pergamon Press, 1974.
Vlattas et al., "Synthesis of 11-oxaprostaglandins" Tetrahedron Letters No. 51/52:4451-4454, XP000644759, Pergamon Press, 1974.
Waterbury, et al., "EP.sub.3, But Not EP.sub.2, FP, or TP Prostanoid-Receptor Stimulation May Reduce Intraocular Pressure" Investigative Ophthalmology and Visual Science 31(120;2560-2567 (1990).
Woodward, et al, "Intraocular Pressure Effects of Selective Prostanoid Receptor Agonists Involve Different Receptor Subtypes According to Radioligand Binding Studies" Journal of Lipid Mediators 6:545-553 c1993).
Woodward et al., "Molecular Characterization and Ocular Hypotensive Properties of the Prostanoid EP.sub.2 Receptor" Journal of Ocular Pharmacology and Therapeutics 11(3):447-454 (1995).
Alcon Laboratories Inc.
Copeland Barry L.
Trinh Ba K.
LandOfFree
Keto-substituted tetrahydrofuran analogs of prostaglandins as oc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Keto-substituted tetrahydrofuran analogs of prostaglandins as oc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Keto-substituted tetrahydrofuran analogs of prostaglandins as oc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117891